Skip to content

Clinical trials

Phase 3 Diabetes Mellitus, Type 2 trials in India

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 3 Country / region: India Clear all

195 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20042
20055
200619
200711
200822
200921
201029
20114
20128
20137
20145
20167
20178
20184
20195
20204
20214
20223
20236
20247
20252
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed161
Terminated17
Recruiting10
Active, not recruiting2
Not yet recruiting2
Withdrawn2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S58
AstraZeneca33
Eli Lilly and Company26
Boehringer Ingelheim18
Sanofi12
Janssen Research & Development, LLC10
Takeda10
GlaxoSmithKline4
Phenomix4
Novartis3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 2195
Diabetes Mellitus68
Glucose Metabolism Disorders16
Dyslipidemias9
Metabolic Diseases9
Endocrine System Diseases8
Obesity8
Overweight8
Cardiovascular Diseases5
Hyperglycemia5

Trials

Showing 1 to 25 of 195. Each trial links to its page on Pharma Observatory.

95 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.